A new biotech company backed by Westlake is targeting migraines. However, the name and details of this company are unclear, as multiple biotech startups have been recently launched with various focuses, including immune drugs, fibrosis drugs, and genetic medicine. The specific company in question has not been clearly identified among the recent launches.